Emerging Scholar, Sami Barmada, MD, PhD, is one of six U-M scientists and engineers receiving the Mid-career Biosciences Faculty Achievement Recognition Award, which recognizes exceptional mid-career faculty in the biosciences.
Dr. Barmada is the Angela Dobson Welch and Lyndon Welch Research Professor and associate professor of neurology, and the institute’s Danto Family Foundation Emerging Scholar. He is a neuroscientist who combines basic biology with translational research to understand critical abnormalities in RNA and protein metabolism in neurodegenerative diseases such as amyotrophic lateral sclerosis and frontotemporal dementia.
In addition to his research, he has taken an active role in raising awareness of ALS and FTD in the community, participating in several local and national fundraising efforts and assisting in setting priorities for national research funding through National Institutes of Health-sponsored panels.
MBioFAR is an annual award established in 2021 by the U-M Biosciences Initiative. It provides discretionary funds — $250,000 per year for two years for each awardee — to encourage innovative, high-risk research.
“These researchers represent the best of U-M’s scientific enterprise and merit MBioFAR recognition. With their passion, inquisitiveness and extraordinary talents, they are committed to improving the human condition,” President Santa J. Ono said.
“The MBioFAR awards recognize exceptional mid-career U-M faculty and provide them with support at this critical stage in their careers to continue their pursuit of the types of novel, boundary-pushing research that can address major challenges in the biological sciences,” said Roger Cone, vice provost, director of the Biosciences Initiative and director of the Life Sciences Institute,
Learn more about Dr. Barmada’s research here.
